Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6891696 | 1.00 | MAPK1 (0.33) | MAPK1 | |
| SCHEMBL6888674 | 0.83 | MAPK1 (0.32) | MAPK1 | |
| SCHEMBL3341014 | 0.78 | MAPK1 (0.31) | MAPK1 | |
| SCHEMBL11076766 | 0.78 | MAPK1 (0.33) | MAPK1 | |
| SCHEMBL2136195 | 0.76 | MAPK1 (0.38) | MAPK1 | |
| SCHEMBL7191367 | 0.76 | CYP1A2 (0.48) | — | |
| SCHEMBL1524898 | 0.75 | CYP1A2 (0.40) | MAPK1 | |
| SCHEMBL297460 | 0.74 | KDM4E (0.32) | MAPK1 | |
| SCHEMBL2138060 | 0.74 | MAPK1 (0.37) | MAPK1 | |
| SCHEMBL11075927 | 0.74 | MAPK1 (0.37) | MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1931687-A2 | PREPARATION OF POLYHEDRAL OLIGOMERIC SILSESQUIOXANE SILANOLS AND SILOXIDES FUNCTIONALIZED WITH OLEFINIC GROUPS | Hybrid Plastics, INC. (US) | 2008-06-18 | — | — | EP | disclosed |
| US-20080051546-A1 | PREPARATION OF POLYHEDRAL OLIGOMERIC SILSESQUIOXANE SILANOLS AND SILOXIDES FUNCTIONALIZED WITH OLEFINIC GROUPS | HYBRID PLASTICS, INC. | 2008-02-28 | — | — | US | disclosed |
| WO-2007022367-A2 | PREPARATION OF POLYHEDRAL OLIGOMERIC SILSESQUIOXANE SILANOLS AND SILOXIDES FUNCTIONALIZED WITH OLEFINIC GROUPS | HYBRID PLASTICS, INC. (US) | 2007-02-22 | — | — | WO | disclosed |